The successful application of gene editing tools has enabled exon skipping or direct correction of nonsense mutations in the dystrophin gene, ultimately restoring dystrophin expression in human, porcine, and murine DMD models [88,89,90]. Here, DMD is linked to Duchenne muscular dystrophy.